Skip to content

Drug interactions

Ranolazine + Tazemetostat

Severity: Moderate

Ranolazine and Tazemetostat: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tazemetostat is a weak-to-moderate CYP3A inducer and a CYP3A substrate, while ranolazine is a weak CYP3A inhibitor and is cleared mainly by CYP3A. Tazemetostat may reduce ranolazine efficacy, while ranolazine is unlikely to meaningfully raise tazemetostat levels.

What this interaction means in plain words

Ranolazine and Tazemetostat can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ranolazine belongs to Cardiovascular; Tazemetostat belongs to Miscellaneous.

Evidence level: Low

Why it happens

CYP3A4 induction by tazemetostat lowering ranolazine levels, with weak CYP3A4 inhibition by ranolazine.

What to do

Monitor for reduced antianginal response to ranolazine and adjust therapy if angina worsens. Avoid combining with strong CYP3A inhibitors in addition.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ranolazine and Tazemetostat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ranolazine with Tazemetostat?

MediHelp rates the interaction as moderate. Ranolazine and Tazemetostat can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tazemetostat is a weak-to-moderate CYP3A inducer and a CYP3A substrate, while ranolazine is a weak CYP3A inhibitor and is cleared mainly by CYP3A. Tazemetostat may reduce ranolazine efficacy, while ranolazine is unlikely to meaningfully raise tazemetostat levels.

How serious is the interaction between Ranolazine and Tazemetostat?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for reduced antianginal response to ranolazine and adjust therapy if angina worsens. Avoid combining with strong CYP3A inhibitors in addition.

What other medicines interact with Ranolazine?

MediHelp also lists interactions of Ranolazine with, for example, Adagrasib, Amobarbital, Apalutamide. The full list is on the Ranolazine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in